All Stories

  1. Microbiome-driven PKs: redefining drug metabolism beyond Host enzymes
  2. Machine learning-based optimization of the prostate health index for prostate cancer detection
  3. Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend
  4. Enhancing the Prediction of Clinically Significant Prostate Cancer Through Feature Engineering
  5. Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence
  6. Clinical advances in investigational epilepsy treatments
  7. Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union
  8. A Case of Paradoxical Appetite Increase During Semaglutide Therapy
  9. Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review
  10. Factors Affecting Thyroid Volume in Children Aged 4 to 18 Years
  11. Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting
  12. Cost Analysis of Hospital Treatment for Peritoneal Dialysis-Associated Peritonitis
  13. Nonchemotherapy drug‐induced cytopenias: A cost‐of‐illness study using the microcosting methodology based on real‐world data
  14. Predictive clinical characteristics for adverse pathological outcomes in intermediate- and high-risk prostate cancer during biopsy
  15. Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia—An Inpatient Welfare Institution-Based Cross-Sectional Study
  16. Using validated model informed precision dosing for dose adjustment: superior evidence needed for efficacy and safety
  17. Clinical Pharmacokinetics and Pharmacodynamics of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
  18. 3D transesophageal echocardiography has benefits in the diagnosis and prognosis of patients with infectious endocarditis
  19. Preventable serious drug-disease interactions of reserve antibiotics
  20. Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models
  21. Risk factors for urinary tract infection and asymptomatic bacteriuria after stroke
  22. Analysis of Reporting Trends of Serious Adverse Events Associated With Anti‐Obesity Drugs
  23. Translation to Serbian and Transcultural Adaptation of the Fraboni Scale of Ageism in a Population of Community Pharmacists
  24. ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
  25. Predicting intermediate-risk prostate cancer using machine learning
  26. Anthropometric Data by Using Bioelectrical Analysis as a Parameters for New Classification and Definition of Obesity
  27. Risk factors for severe adverse drug reactions in hospitalized patients
  28. Physiologically based pharmacokinetic and toxicokinetic modeling: A multidisciplinary approach to drug development and ecotoxicology
  29. Vitamin K epoxide reductase complex subunit 1 gene promoter polymorphism - a potential genetic basis for survival from thromboembolism in COVID-19
  30. Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures
  31. <em>ABCB1</em> Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
  32. Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature
  33. New Scale Measuring Willingness to Deliver Pharmaceutical Care to Elderly (WPhCAReELD Scale)
  34. Novel Insights into Amlodipine-Induced Gingival Enlargement: A Clinical and Molecular Perspective
  35. Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults
  36. Predictors of Intrahospital Mortality in Aneurysmal Subarachnoid Hemorrhage after Endovascular Embolization
  37. Predictors Of Marketing Authorization Status Of Dipyrone Within A Country
  38. POPULATION PHARMACOKINETICS OF PANTOPRAZOLE IN PATIENTS ON DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME
  39. Validation of Novel High-Performance Liquid Chromatography Method for Meropenem Quantification in Plasma
  40. Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
  41. Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions
  42. Factors Associated with Abnormal Uterine Bleeding in Perimenopausal Women
  43. Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
  44. Multidisciplinary teams in healthcare
  45. Add-on antihypertensives for treatment of resistant hypertension: An extension of the TRYCORT study
  46. Antiobesity drugs utilization trend analysis and reimbursement lists status: The perspective of selected European countries
  47. Biomarkers of inflammation and multisystem tissue and organ damage in patients with COVID-19
  48. Diagnostic agreement of presepsin, procalcitonin, C-reactive protein and white blood cell count in patients with suspected sepsis
  49. Improving estimate of cost/effectiveness of drugs for rare diseases
  50. Patient blood management: Team working between clinical transfusiology and clinical pharmacology
  51. Population pharmacokinetics of vancomycin in hemodialysis patients
  52. Long-term outcomes in refractory status epilepticus
  53. Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
  54. Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis
  55. Factors affecting outcome in hospitalized patients treated according to recommendations from clinical pharmacologists
  56. Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension
  57. Enhanced PSA Density Prediction Accuracy When Based on Machine Learning
  58. Guidance for interactions between antiseizure medications
  59. Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
  60. Healing Factors of Decubital Lesions in Denture Wearers
  61. SGLT2 Inhibitors: A Systematic Review for Heart Failure Treatment
  62. Investigational new drugs for the treatment of Dravet syndrome: an update
  63. Predictors of Mortality in Early Neonatal Sepsis: A Single-Center Experience
  64. Hypovitaminosis D in infants: Evidence that increased intake of vitamin D reduces the incidence of allergic and respiratory disorders
  65. Psychometric Properties of the Persian Version of Fear of Hospitalization Scale in Patients Undergoing Emergency Surgery
  66. Testing of new instrument for measuring quality and diversity of nutrition in pregnancy
  67. Acute toxicity threshold of normobaric oxygen therapy: Systematic review
  68. Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression
  69. Kounis Syndrome Associated With the Use of Diclofenac
  70. Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic Review
  71. Improved Prediction of Significant Prostate Cancer Following Repeated Prostate Biopsy by the Random Forest Classifier
  72. Meta‐analysis of peripheral insulin‐like growth factor 1 levels in schizophrenia
  73. Factors Associated with Potentially Inappropriate Prescribing in Patients on Peritoneal Dialysis
  74. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation
  75. Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review
  76. Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review
  77. Advancements in neuroactive peptides in seizures
  78. Reduction of direct and indirect costs of treatment of patients with type 2 diabetes due to good glycemic control and reduced frequency of complications
  79. Risks factors of prolonged hospitalization in COVID-19 patients
  80. Toxic megacolon after irrational antibiotic treatment of pregnat patient with Covid 19: Case report
  81. Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning
  82. Novel and emerging therapeutics for genetic epilepsies
  83. Antimicrobial treatment of Morganella morganii invasive infections: Systematic review
  84. Effects of Supplementation in Vitamin D3 Deficient or Insufficient Children with Allergic Diseases
  85. Personalization of drug dose thematic issue: introduction article
  86. Risk factors for potential drug–drug interactions in patients with myasthenia gravis
  87. Treating of focal epilepsy: a patent review
  88. <b>Quality of Life Assessment in Type 2 Diabetes Patients With Cardiovascular and/or Diabetic Complications</b>
  89. Does the Severity of Obstructive Sleep Apnea Have an Independent Impact on Systemic Inflammation?
  90. New instrument for measuring quality of life in patients with cervical cancer
  91. Characteristics of COPD Phenotypes in Serbia
  92. Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
  93. Inflated Co-authorship Introduces Bias to Current Scientometric Indices
  94. Accuracy of serum procalcitonin, C-reactive protein and soluble CD14 subtype levels in diagnosis of sepsis in children
  95. DRESS syndrome without eosinophilia induced by Carbamazepine: A case report
  96. Focus group and Delphi process: Stroke and potential drug-drug Interactions (pDDI) in the neurological Intensive Care Unit (NICU)
  97. Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
  98. Method for adjusting results of pharmacoeconomic studies from country to country using Bayesian statistics
  99. Risk factors for potential drug-drug interactions in a general neurology ward
  100. The QTc interval and treatment outcome of inpatients with COVID-19
  101. Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa
  102. Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?
  103. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
  104. Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance
  105. Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE
  106. Evaluation of zonisamide for the treatment of focal epilepsy: a review of pharmacokinetics, clinical efficacy and adverse effects
  107. Predictors of antibiotic utilization among intensive care unit patients
  108. Antiviral therapy of COVID-19
  109. Drug rash with eosinophilia and systemic symptoms syndrome in an adolescent - efficiency of immunoglobulin G in a corticosteroid resistant case
  110. Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis
  111. Geopolitical thought in the Apennine peninsula: Teachers and students
  112. Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa
  113. Translation to Serbian and transcultural adaptation of the oral health-related quality of life [OHQoL-UK(W)] instrument
  114. The Basic Principles of Editing Biomedical Scientific Journals
  115. Correlation between laboratory parameters and COVID-19 treatment outcome
  116. Local guidelines for drug treatment of patients with COVID-19
  117. Surgical Fear Questionnaire (SFQ) - Serbian cultural adaptation
  118. The reasons for development of complications in soft contact lenses wearers: A qualitative study
  119. Editing Medical Journals B
  120. Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost–benefit ratios and prevalence
  121. Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy
  122. A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization
  123. Contemporary surgical management of drug-resistant focal epilepsy
  124. Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of Plasmodium vivax malaria
  125. Screening general practice patients for migraine without aura: construction and validation of the Balkan Migraine Screening Questionnaire (BMSQ)
  126. Antimicrobial treatment of Kocuria kristinae invasive infections: Systematic review
  127. Effects of local guidelines on prescribing practice and treatment outcomes in a long-stay psychiatric facility
  128. Pandrug-resistant Pseudomonas aeruginosa isolated from qualitative endotracheal aspirate could rather be contaminant than causative agent of respiratory infections in intensive care unit patients: Case study
  129. Predictors of potential drug-drug interactions in patients at intensive care unit
  130. Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
  131. Development and validation of a questionnaire for measuring drug-induced nausea
  132. Factors influencing extent of nausea in the patients on oral iron therapy
  133. Performance of a calculator for diagnosing the cause of liver damage
  134. Psychometric properties of the Headache Under-Response to Treatment (HURT) questionnaire and the Migraine Disability Assessment Test (MIDAS) translated to Serbian
  135. Where next for antiepileptic therapeutic drug monitoring?
  136. Antimicrobial Activity of Aqueous Extracts of Potentilla Reptans L. Rhizome and Aerial Part
  137. Drug–drug interactions in patients receiving hematopoietic stem cell transplantation
  138. Drug–drug interactions in patients with acute coronary syndrome across phases of treatment
  139. Pharmacokinetics of vancomycin in patients with different renal function levels
  140. Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review
  141. Investigational cannabinoids in seizure disorders, what have we learned thus far?
  142. Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections
  143. A questionnaire to measure how much a patient is afraid of being admitted to a hospital.
  144. A Questionnaire for Assessing Fear of Radiotherapy in Oncology Patients
  145. Delirium Risk Factors in Elderly Patients Suffering from Femoral Neck Fractures
  146. Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
  147. Analysing factors which influence treatment outcomes by multivariable linear regression
  148. Calculation of drug dose which produces 'all-or-nothing' response in 50% of subjects (effective dose 50) using probits
  149. The role of a pharmacist in prevention and detection of OTC drug interactions: Nominal group technique
  150. Modern approach to the therapy of infections caused by Clostridium difficile
  151. Risk factors for nosocomial infections in mechanically ventilated neonates at intensive care unit
  152. Alarm system for surveillance of patients receiving high doses of radioiodine (131I) therapy in the case of unauthorised abandoning of a controlled area
  153. The study of the Middle East in the Journal International Problems between 1950 and 1990
  154. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs
  155. Evaluation of brivaracetam: a new drug to treat epilepsy
  156. Population Pharmacokinetic Analysis of Bisoprolol in Patients with Stable Coronary Artery Disease
  157. Factors Influencing the Fear of Needles among Students of Medicine and Pharmacy
  158. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit
  159. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children
  160. Translation, Cultural Adjustment and Evaluation of Reliability and Validity of “Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form” for Patients with Schizophrenia
  161. Psychometric Development of Chemotherapy Side Effects Fear Scale
  162. Development and Validation of the Questionnaire for the Evaluation of Knowledge about Herbal Preparations (QEK-HP)
  163. Factors associated with the rate of COPD exacerbations that require hospitalization
  164. Antiepileptic potential of ganaxolone
  165. Translation to Serbian, cultural adaptation, reliability testing and validation of the questionnaire estimating the fear of injections
  166. Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis
  167. Clinical and laboratory parameters associated with death in acute pancreatitis
  168. Predictors of involuntary hospitalisation of patients suffering from schizophrenia
  169. Effects of antidepressants on serum concentrations of bone metabolism markers and major electrolytes in patients from routine psychiatric practice
  170. Hospital infections rate and health staff density in a Neonatology Department
  171. Translation to Serbian, Transcultural Adaptation and Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM- ICU)
  172. Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii
  173. Consulting clinical pharmacologist about treatment of inpatients in a tertiary hospital in Serbia
  174. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
  175. Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome
  176. Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
  177. The psychometric properties of the Comprehensive Headache-related Quality of life Questionnaire (CHQQ) translated to Serbian
  178. The impact of cardiovascular drugs on the efficacy of local anesthesia in dentistry
  179. Effects of cardiovascular drugs on TSH serum levels in patients on replacement therapy after thyroidectomy
  180. Pharmacokinetics of linezolid in critically ill patients
  181. CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy
  182. Population Pharmacokinetics of Bisoprolol in Hemodialysis Patients with Hypertension
  183. Analysis of Treatment-Related Factors Affecting Mortality in Patients with Severe Necrotizing Acute Pancreatitis
  184. Hospital-Acquired Pneumonia in Newborns with Birth Weight Less Than 1500 Grams: Risk Factors and Causes
  185. Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins
  186. Measuring Potential of Preschool Facility Staff to Prevent Early Childhood Caries
  187. Neutropenia induced by non-cytotoxic drugs
  188. Headache in patients undergoing general anesthesia
  189. Drug-related problems in patients with osteoporosis
  190. Frequency of headache in oncology patients undergoing radiotherapy
  191. Factors affecting inappropriate prescription of antibiotics and the emergence of antibiotic resistance in patients in primary health care
  192. Factors influencing knowledge transfer from faculty to PhD students
  193. Factors associated with early treatment failure in adult hospitalized patients with community-acquired pneumonia
  194. Markers of inflammation as risk predictors of lethal outcome in patients diagnosed with delirium
  195. Risk factors for healthcare-acquired urinary tract infections caused by multi-drug resistant microorganisms
  196. Etiology and resistance patterns of bacteria causing ventilator-associated pneumonia in a medical intensive care unit
  197. Parameters of Calcium Metabolism Fluctuated during Initiation or Changing of Antipsychotic Drugs
  198. Quality of life in patients early after surgery
  199. Neuroleptic malignant syndrome: the diagnostic dilemma
  200. Community-acquired urinary tract infections: Causative agents and their resistance to antimicrobial drugs
  201. Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro
  202. The importance of early recognition and timely treatment of delirium in intensive care units
  203. Measuring Patientsʼ Knowledge About Adverse Effects of Angiotensin-Converting Enzyme Inhibitors
  204. Vectors of Turkish foreign policy: What remains of the strategy for 2023?
  205. P-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration
  206. MANAGEMENT OF CLINICALLY CURED TONSILLOPHARYNGITIS IN PATIENTS WITH GROUP A STREPTOCOCCUS ISOLATED FROM A PHARYNGEAL SWAB
  207. IMPROVING ANTIPSYCHOTICS PRESCRIBING BY PHARMACEUTICAL CARE
  208. Risk factors for potentially inappropriate prescribing to older patients in primary care
  209. Epidemiology and Treatment Guidelines of Negative Symptoms in Schizophrenia in Central and Eastern Europe: A Literature Review
  210. Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter
  211. THYRPAN-TM Prototype: New System for Online Telemonitoring of Patients with Thyroid Carcinoma During the Treatment with a High Dose of Radioiodine
  212. Predictors of Length of Stay in Patients with Spinal Cord Injury
  213. The use of dry Jerusalem artichoke as a functional nutrient in developing extruded food with low glycaemic index
  214. Analiza efektywności kosztowej terapii dronedaronem w porównaniu z leczeniem amiodaronem, propafenonem i sotalolem w grupie chorych z migotaniem przedsionków: wyniki badania przeprowadzonego w Serbii
  215. Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach
  216. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
  217. Reasons for Inadequate Vaccination after Splenectomy
  218. Perifocal oedema after endovascular embolization
  219. Early Cytokine Profile Changes In Interstitial And Necrotic Forms Of Acute Pancreatitis
  220. CYP3A5 Polymorphism In Serbian Paediatric Epileptic Patients On Carbamazepine Treatment
  221. Risk Factors For Development Of Acute Necrotizing Pancreatitis
  222. Quality Of Life Among Patients With Depression
  223. Lack Of PRSS1 And SPINK1 Polymorphisms In Serbian Acute Pancreatitis Patients
  224. Treatment of hypokalemia
  225. Drug-induced immune thrombocytopenia
  226. Drug treatment and prevention of postoperative headache
  227. Prevention and treatment of postoperative vomiting
  228. Calcitonin Gene-Related Peptide Receptor Blocker Inhibits Spontaneous Activity of Human Ureter
  229. Transplantation through the ages
  230. Adjuvant drug therapy of bleeding from gastric or duodenal ulcer
  231. Costs of benign prostatic hyperplasia treatment in Montenegro
  232. Analysis of the costs of treating dry socket
  233. Cognitive status of persons under guardianship living in a social welfare institution
  234. Analysis of risk factors for occlusions of a synthetic femoropopliteal bypass graft
  235. Improving clinical drug development regulatory procedures for anticonvulsants
  236. Assessment of the reliability of the Serbian version of the sickness impact profile questionnaire in patients with chronic viral hepatitis
  237. Long-term treatment with olanzapine in hospital conditions: Prevalence and predictors of the metabolic syndrome
  238. Cost-effectiveness of depressive episode pharmacological treatment
  239. Risk factors for the development of metabolic syndrome in obese children and adolescents
  240. Impact of educational intervention on prescribing inappropriate medication to elderly nursing homes residents
  241. Population pharmacokinetics of 25-hydroxyvitamin D in healthy young adults
  242. Health care–acquired infections in neonatal intensive care units: Risk factors and etiology
  243. Attitudes of PhD students towards qualitative research methods in medicine
  244. Interaction between tigecycline and human serum albumin in aqueous solution
  245. generic versus brand anticonvulsants
  246. Rational therapy publication rate correlates with wealth of a society
  247. Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition
  248. Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implications
  249. Comparison of EMA and FDA guidelines for drug interactions: An overview
  250. Hypocalcaemia: Causes, diagnostics and treatment
  251. Prescribing Antipsychotics in Montenegro: a Focus Group Analysis
  252. Medical emergencies facing general practitioners: Drugs for the doctor's bag
  253. Prevalence and predictors of potential drug-drug interactions
  254. The effects of microwave radiation on microbial cultures
  255. The Influence of Antipsychotics on the Quality of Life of Patients with Schizophrenia in a Long-stay Psychiatric Facility
  256. Risk factors for severe dental anxiety among medical students
  257. Comparative analysis of the chemical composition and antimicrobal activities of some of Lamiaceae family species and Eucaliptus (Eucaliptus globules M)
  258. Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition
  259. Preparation, characterization and antimicrobial activity of chitosan microparticles with thyme essential oil
  260. Analysis of the Factors Influencing Functional Outcomes in Patients with Spinal Cord Injury
  261. Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country – examples of Serbia and Belgium
  262. Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: Sensitivity to antibiotics and risk factors
  263. Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilization
  264. Influence of dialysis modality and membrane flux on insomnia severity in haemodialysis patients
  265. The preclinical discovery and development of ezogabine for the treatment of epilepsy
  266. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia
  267. Population Pharmacokinetics of Carvedilol in Patients with Congestive Heart Failure
  268. Captopril May Influence Tone of Human Oviduct Ampulla
  269. An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure
  270. PhD Students’ Awareness of Research Misconduct
  271. Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents
  272. Cushing’s syndrome diagnosed after delivery: a case report
  273. Adequate doctor - patient communication
  274. Population pharmacokinetic of antiepileptic drugs in different populations
  275. A report of a medication error: Drug incompatibility
  276. Cardiotoxicity of Palladium Compounds / Kardiotoksičnost Jedinjenja Paladijuma
  277. Submissiveness to health authorities as an obstacle to practicing evidence based medicine
  278. Profile of urinary tract infections pathogens and their antimicrobial resistance patterns during three-year period (2009-2011) in the Clinical center Kragujevac
  279. Rituximab for the treatment of rheumatiod arthritis patients with failure to the first biologic drug: Impact on Republic fund for health insurance in Serbia
  280. Zuclopenthixol decanoate in pregnancy: Successful outcomes in two consecutive off springs of the same mother
  281. Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control study
  282. Comparative analysis of the chemical composition of Heliantus tuberosus L. growing in Serbia and Romania
  283. Comparison of three methods used for measurement of radioiodine fixation in thyroid gland of mice
  284. Hospital infections in a neurological intensive care unit: incidence, causative agents and risk factors
  285. Population pharmacokinetics of bisoprolol in patients with chronic heart failure
  286. Effects of aurothiomalate and gold(III) complexes on spontaneous motility of isolated human oviduct
  287. Online Remote Monitoring of Patients with Differentiated Thyroid Carcinomas and Neuroendocrine Tumors Treated with High Doses of Radionuclides
  288. Chemical and Antimicrobial Evaluation of Supercritical and Conventional Sideritis scardica Griseb., Lamiaceae Extracts
  289. Toxic Effects of Palladium Compounds on the Isolated Rat Heart
  290. Utilization of non-steroidal anti-inflammatory drugs in General and Endocrine Surgery Ward at Clinical Center 'Kragujevac' in Kragujevac
  291. Factors associated with hospitalization of children with acute odontogenic infections
  292. Factors associated with death in intensive care unit patients with ventilator-associated pneumonia
  293. Role of anticonvulsant therapeutic drug monitoring in improving clinical outcomes: An example of 12 adult epilepsy patients
  294. Secondary complications and associated injuries in traumatic and non-traumatic spinal cord injury patients
  295. Demographic characteristics and functional outcomes in patients with traumatic and nontraumatic spinal cord injuries
  296. Secondary complications and associated injuries in traumatic and non-traumatic spinal cord injury patients
  297. Risk factors for behavioural and emotional disorders in children with mild intellectual disability
  298. Predictors of pressure ulcers in patients with spinal cord injuries
  299. Risk factors for behavioural and emotional disorders in children with mild intellectual disability
  300. Effects of a Facebook profile devoted to drug use in pregnancy on the discovery of inappropriate drug use by pregnant females in the former Yugoslav republics
  301. Effects of a Facebook profile devoted to drug use in pregnancy on the discovery of inappropriate drug use by pregnant females in the former Yugoslav republics
  302. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects
  303. Changes of platelets’ function in preeclampsia
  304. N-acetyltransferase-2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population
  305. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis
  306. Gallbladder Emptying in Patients with Major Depression: A Case Series
  307. Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health care
  308. Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions
  309. Embolization of ruptured intracranial aneurysms with detachable coils: case series
  310. Effects of Methyldopa and Nifedipine on Uteroplacental and Fetal Hemodynamics in Gestational Hypertension
  311. Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
  312. Electrolyte disorders associated with risperidone in psychotic patients
  313. Quality of life in patients with multiple sclerosis
  314. Metabolic syndrome in children and adolescents
  315. Of the phytochemical research performed to date on sideritis species
  316. The methodology of determining antibacterial activity of plant extracts with disk-diffusion method in vitro
  317. Risk factors for early postoperative arrhythmias in general surgery patients after general anesthesia
  318. Differentiation between opiate addicts in relation to judicial problems
  319. Adverse events induced by anti-infectives in hospitalized patients
  320. Attitudes towards antipsychotic drugs and their side effects: A comparison between students of medicine in Spain and Serbia
  321. Quality of life of schizophrenic patients treated with haloperidol depot and injection preparation of long-lasting risperidone
  322. Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women
  323. Non-invasive screening: The probability of events
  324. Resistance rates of Pseudomonas aeruginosa and Acinetobacter species causing ventilator-associated pneumonia do not always correlate with utilisation of antibiotics
  325. Risperidone-Associated Hypocalcemia
  326. Factors influencing valproate pharmacokinetics in children and adults
  327. Aliskiren and angioedema
  328. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
  329. Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
  330. In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population
  331. Pharmacokinetic modelling of valproate in epileptic patients
  332. Antihypertensive drugs utilisation and educational activities
  333. Risk factors for recurrent vulvovaginal candidiasis
  334. A Nonlinear Mixed Effects Modelling Analysis of Topiramate Pharmacokinetics in Patients with Epilepsy
  335. The contractile effects of endothelins on isolated isthmic segment of human oviduct at the luteal phase of the menstrual cycle
  336. Monitoring of drug-associated electrolyte disturbances in a hospital
  337. Unexpected Effect of Furosemide on Radioiodine Urinary Excretion in Patients with Differentiated Thyroid Carcinomas Treated with Iodine 131
  338. Effects of Exogenous Glutamate and Kainate on Electric Field-stimulated Contractions of Isolated Human Ureter
  339. Costs of Rheumatoid Arthritis in a Balkan Country (Serbia)
  340. Renal transplantation vs hemodialysis: Cost-effectiveness analysis
  341. Significance of herbal drugs legislation for their rational use
  342. Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia
  343. Current clinical evidence on topiramate pharmacokinetics
  344. Cost-effectiveness of four immunomodulatory therapies for relapsingremitting multiple sclerosis: A Markov model based on data a Balkan country in socioeconomic transition
  345. Contractile effects of endothelins on isolated ampullar segment of human oviduct in luteal phase of menstrual cycle
  346. Effects of cisplatin and other Pt(II) complexes on spontaneous motility of isolated human oviduct
  347. Risk factors for treatment failure in renal suppurative infections
  348. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy
  349. Cost-Effectiveness of Ritodrine and Fenoterol for Treatment of Preterm Labor in a Low–Middle-Income Country: A Case Study
  350. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients
  351. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
  352. Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics
  353. Serum and Uterine Concentrations of Cefazolin, Cefuroxime, and Ceftriaxone After Intraoperative Prophylactic Administration During Cesarean Section
  354. Effect of exogenous glutamate and N-Methyl-D-aspartic acid on spontaneous activity of isolated human ureter
  355. Pathogenic mechanisms in the development of surgical site infections
  356. Clinical pharmacology in Serbia: The time for new challenges
  357. Drug utilisation patterns in Zabljak municipality, Serbia and Montenegro
  358. Pharmacokinetic modelling of valproate from clinical data in Serbian epileptic patients
  359. Middle East conflicts: Basic features
  360. Inhibitory effects of selected antiepileptics on spontaneous motility of isolated human oviducts
  361. Characteristics of decision-making process during prescribing in general practice
  362. National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
  363. Prevention of spreading of avian influenza in medical care facilities
  364. Impact of clinical pharmacology on health care: Serbian experience
  365. Population pharmacokinetics
  366. Clinical pharmacology in health care service
  367. Renal Adverse Effects of Interferon-??
  368. Effect of the exogenous glutamate and the NMDA on electric field-stimulated contractions of isolated rat ileum
  369. Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country
  370. Osnovi glutamatergicke neurotransmisije
  371. Mere za unapredjenje lekarske prakse
  372. Farmakologija receptora i celijskih transportera za glutamat
  373. Contractile effect of acetylcholine on isolated isthmic segment of fallopian tubes
  374. Contractile effect of acetylcholine on isolated ampullar segment of fallopian tubes
  375. Semi-Intensive Versus Intensive Monitoring of Adverse Drug Reactions in a Hospital
  376. Comparison of efficacy and safety between individualized and empiric dose regimen of amitriptyline in the treatment of major depressive episode
  377. Stimulating Spontaneous Reporting of Adverse Drug Reactions by a Patient
  378. Effect of intratumoral application of methotrexate in vivo on frequency of micronuclei in peripheral blood lymphocytes
  379. Slobodan Jankovic
  380. Whether use of antipsychotics in psychogeriatric facilities is appropriate?
  381. A pharmacological analysis of the contractile effects of glutamate on rat and human isolated gut smooth muscle strips
  382. Antipsychotic Drug Prescription in a Serbian Long-Stay Psychiatric Care Facility
  383. EFFECTS OF NICOTINE, DIMETHYLPHENYLPIPERAZINIUM AND TETRAMETHYLAMMONIUM ON SMOOTH MUSCLES FROM FELINE AND HUMAN GASTRIC CORPUS
  384. THE EFFECTS OF EXCITATORY AMINO ACIDS ON ISOLATED GUT SEGMENTS OF THE RAT
  385. A study of the effect of benzylpenicillin on isolated human gallbladder
  386. The control of hair growth
  387. DIFFERENCES IN THE EFFECTS OF VASOPRESSIN AND OXYTOCIN ON FELINE GASTRIC CORPUS MOTILITY: SELECTIVE ACTION OF VASOPRESSIN ON LONGITUDINAL MUSCLE